Inventor · disambiguated record
J. Gordon Foulkes
Also filed as: FOULKES J G · FOULKES J GORDON
21 granted patents·14 pending applications·734 citations·filing 1990–2019
96Inventor score
Files withONCOGENE SCIENCE INC8DEAN NICHOLAS M6OSI PHARM INC6EXCALIARD PHARMACEUTICALS INC4BEELEY NIGEL ROBERT ARNOLD2
Top patents by PatentIndex Score
35 records- 0195US5665543AMethod of discovering chemicals capable of functioning as gene expression modulatorsONCOGENE SCIENCE INC·Filed 1994·Granted Sep 9, 1997·110 cites·26 claims
- 0294US6165712AMethods of transcriptionally modulating expression of viral genes and genes useful for production of proteinsOSI PHARM INC·Filed 1995·Granted Dec 26, 2000·120 cites·23 claims
- 0389US5776502AMethods of transcriptionally modulating gene expressionONCOGENE SCIENCE INC·Filed 1995·Granted Jul 7, 1998·83 cites·20 claims
- 0487US5580722AMethods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular diseaseONCOGENE SCIENCE INC·Filed 1992·Granted Dec 3, 1996·115 cites·7 claims
- 0585US6136779AMethods of specifically transcriptionally modulating the expression of gene of interestOSI PHARM INC·Filed 1997·Granted Oct 24, 2000·48 cites·40 claims
- 0683US8252762B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofDEAN NICHOLAS M·Filed 2009·Granted Aug 28, 2012·5 cites·25 claims
- 0782US5262319AMethod for obtaining bone marrow free of tumor cells using transforming growth factor β3ONCOGENE SCIENCE INC·Filed 1990·Granted Nov 16, 1993·47 cites·1 claims
- 0880US5846720AMethods of determining chemicals that modulate expression of genes associated with cardiovascular diseaseONCOGENE SCIENCE INC·Filed 1996·Granted Dec 8, 1998·68 cites·7 claims
- 0976US9096851B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofDEAN NICHOLAS M·Filed 2012·Granted Aug 4, 2015·2 cites·51 claims
- 1075US6203976B1Methods of preparing compositions comprising chemicals capable of transcriptional modulationOSI PHARM INC·Filed 1994·Granted Mar 20, 2001·31 cites·26 claims
- 1174US6977152B2Biological assays using coded RNA reportersVIRTUAL ARRAYS INC·Filed 2002·Granted Dec 20, 2005·7 cites·22 claims
- 1273US5863733AMethods of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulatorsONCOGENE SCIENCE INC·Filed 1997·Granted Jan 26, 1999·33 cites·26 claims
- 1369US5976793AMethods of transcriptionally modulating gene expression and of discovering chemicals capable as gene expression modulatorsONCOGENE SCIENCE INC·Filed 1996·Granted Nov 2, 1999·23 cites·25 claims
- 1465US9173894B2Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF)DEAN NICHOLAS M·Filed 2012·Granted Nov 3, 2015·1 cites·27 claims
- 1565US2008009060A1Methods of discovering chemicals capable of functioning as gene expression modulatorsFOULKES J G·Filed 2007·Application pending·0 cites
- 1664US5824297ATissue-derived tumor growth inhibitors, methods of preparation and uses thereofONCOGENE SCIENCE INC·Filed 1993·Granted Oct 20, 1998·25 cites·29 claims
- 1764US2020190521A1Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)DEAN NICHOLAS M·Filed 2019·Application pending·0 cites
- 1860US2003166281A1Methods of discovering chemicals capable of functioning as gene expression modulatorsOSI PHARM INC·Filed 2002·Application pending·0 cites
- 1959US8772260B2Methods for inhibiting expression of connective tissue growth factorDEAN NICHOLAS M·Filed 2012·Granted Jul 8, 2014·0 cites·27 claims
- 2059US2019323013A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2155US2017335329A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2252US9688987B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·0 cites·59 claims
- 2352US6376175B1Methods of discovering chemicals capable of functioning as gene expression modulatorsOSI PHARM INC·Filed 1998·Granted Apr 23, 2002·4 cites·25 claims
- 2450US11865113B2Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)LIPIDIO PHARMACEUTICALS INC·Filed 2017·Granted Jan 9, 2024·0 cites·9 claims
- 2549US2005084914A1Assays with primary cellsFiled 2004·Application pending·0 cites
- 2645US2002025940A1Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and use for cellular assays in drug discoveryAURORA BIOSCIENCES CORP·Filed 2001·Application pending·0 cites
- 2744US5871724ATissue-derived tumor growth inhibitors, methods of preparation and uses thereofO S I PHARMACEUTICALS INC·Filed 1995·Granted Feb 16, 1999·10 cites·32 claims
- 2842US2011172296A1Modulation of transforming growth factor-beta 1 expressionBENNETT C FRANK·Filed 2011·Application pending·0 cites
- 2939US6589733B1Methods of preparing compositions comprising chemicals capable of transcriptional modulatorsOSI PHARM INC·Filed 1995·Granted Jul 8, 2003·2 cites·26 claims
- 3039US2018118707A1Beta-naphthoisoflavones, compositions containing, and uses of, sameTHESAN PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3138US2018179174A112H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAMEBEELEY NIGEL ROBERT ARNOLD·Filed 2016·Application pending·0 cites
- 3238US2011213011A1Modulation of smad3 expressionDEAN NICHOLAS M·Filed 2011·Application pending·0 cites
- 3337US2017022501A1Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)EXCALIARD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3432US2018185325A112H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAMEBEELEY NIGEL ROBERT ARNOLD·Filed 2016·Application pending·0 cites
- 3531US2003138773A1Methods of transcriptionally modulating gene expressionFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when J. Gordon Foulkes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →